Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Borchmann

Showing results (71-80 of 252) with videos related to

Pageof 26
Sort By:
Cancers|March 11, 2020
FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma-An Updated OverviewConrad-Amadeus Voltin, Jasmin Mettler, Jirka Grosse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study groupBeate Klimm, Jeremy Franklin, Harald Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2019
Predictive Value of Positron Emission Tomography/Computed Tomography After ABVD-Based Chemotherapy in Early-Stage Hodgkin LymphomaCarsten Kobe, Helen Goergen, Michael Fuchs, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 15, 2021
Moving the goalposts while scoring-the dilemma posed by new PET technologiesJulian M M Rogasch, Ronald Boellaard, Lucy Pike, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 4, 2023
The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologistsMichael Oertel, Christian Berdel, Gerhard Held, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Depletion of cellular cholesterol and lipid rafts increases shedding of CD30Bastian von Tresckow, Karl-Josef Kallen, Elke Pogge von Strandmann, et al.
Leukemia & Lymphoma|March 29, 2011
Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphomaPeter Borchmann, Raoul Herbrecht, Martin Wilhelm, et al.
Academic Radiology|December 28, 2023
PET/CT Reconstruction and Its Impact on [Measures of] Metabolic Tumor VolumeHenry Knaup, Jasmin Weindler, Lutz van Heek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2015
Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 TrialsHeinz Haverkamp, Boris Böll, Dennis A Eichenauer, et al.
Leukemia & Lymphoma|December 4, 2018
Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study GroupStefanie Kreissl, Helen Goergen, Horst Müller, et al.
Pageof 26

Showing results (71-80 of 252) with videos related to

Sort By:
Pageof 26
Cancers|March 11, 2020
FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma-An Updated OverviewConrad-Amadeus Voltin, Jasmin Mettler, Jirka Grosse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study groupBeate Klimm, Jeremy Franklin, Harald Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2019
Predictive Value of Positron Emission Tomography/Computed Tomography After ABVD-Based Chemotherapy in Early-Stage Hodgkin LymphomaCarsten Kobe, Helen Goergen, Michael Fuchs, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 15, 2021
Moving the goalposts while scoring-the dilemma posed by new PET technologiesJulian M M Rogasch, Ronald Boellaard, Lucy Pike, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 4, 2023
The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologistsMichael Oertel, Christian Berdel, Gerhard Held, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Depletion of cellular cholesterol and lipid rafts increases shedding of CD30Bastian von Tresckow, Karl-Josef Kallen, Elke Pogge von Strandmann, et al.
Leukemia & Lymphoma|March 29, 2011
Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphomaPeter Borchmann, Raoul Herbrecht, Martin Wilhelm, et al.
Academic Radiology|December 28, 2023
PET/CT Reconstruction and Its Impact on [Measures of] Metabolic Tumor VolumeHenry Knaup, Jasmin Weindler, Lutz van Heek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2015
Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 TrialsHeinz Haverkamp, Boris Böll, Dennis A Eichenauer, et al.
Leukemia & Lymphoma|December 4, 2018
Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study GroupStefanie Kreissl, Helen Goergen, Horst Müller, et al.
Pageof 26